Skip to main content
Top

25-09-2024 | Acute Kidney Injury | Original Article

Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey

Authors: Ilyas Ozturk, Ozkan Gungor, Savas Ozturk, Refik Olmaz, Ayse Jini Gunes Keskin, Ismail Kocyigit, Murat Hayri Sipahioglu, Fatih Dede, Sena Ulu, Kenan Turgutalp, Dilek Torun, Tuncay Sahutoglu, Fatih Mehmet Erdur, Orcun Altunoren, Ramazan Danis, Gursel Yildiz, Ali Gurel, Mehmet Horoz, Mehmet Kucuksu, Suleyman Karakose, Tolga Yildirim, Mehmet Riza Altiparmak, Mehmet Deniz Ayli, Murat Tugcu, Zehra Eren, Eray Eroglu, Yasemin Coskun Yavuz, Esra Akcali, Dede Sit, Mehmet Polat, Saliha Yildirim, Selma Alagoz, Sibel Gokcay Bek, Irem Pembegul, Tahsin Karaaslan, Mustafa Keles, Funda Sari, Ustun Yilmaz, Numan Gorgulu, Gulizar Sahin, Zeki Aydin, Serap Yadigar, Ozkan Ulutas, Nedim Yilmaz Selcuk, Yavuz Ayar, Didem Turgut, Ozgur Akin Oto, Mehmet Koc, Alaattin Yıldız, Serhan Tuglular, Mehmet Sukru Sever

Published in: Journal of Nephrology

Login to get access

Abstract

Background

Each year, millions face natural disasters, encountering mass fatalities and severe medical issues such as crush injuries and crush syndrome. Crush syndrome, marked by acute kidney injury (AKI) and hyperkalemia, correlates with mortality. This study focuses on presenting epidemiological data on kidney disease resulting from the February 6, 2023 earthquakes centered in Kahramanmaras.

Methods

This retrospective analysis included patients diagnosed with crush syndrome after the 2023 Kahramanmaras earthquakes, treated in regional hospitals or referred elsewhere in Turkey. Patient data were documented using the web-based system developed by the Turkish Nephrology Association Renal Disaster Working Group.

Results

Of the 1024 analyzed patients from 46 centers, 515 (50.3%) were women. The mean age was 41 ± 16 years, with a median duration of 12 h under rubble, and the median presentation time to the first health facility was 4 h after extrication from the rubble. Upon admission, 79.8% received intravenous fluid therapy, all potassium-free. Initial serum creatinine, K+, and creatinine kinase levels averaged 2.59 ± 2 mg/dl, 5.1 ± 1 mmol/L 38,305 ± 54,303 U/L, respectively. Intensive care unit (ICU) admissions were 53.6%, with mean hospital and ICU stays of 20 and 11 days, respectively. Compartment syndrome occurred in 40.8% of patients, with 75.8% undergoing fasciotomy. Acute kidney injury developed in 67.9% of patients, with 70.3% undergoing hemodialysis, totaling 3016 sessions on 488 patients. The overall in-hospital mortality rate was 9.8%.

Conclusion

Earthquakes have a significant impact on kidney health. Although our study indicates some progress compared to previous earthquake responses, there remains a crucial need for drills emphasizing post-earthquake initial response, fluid-electrolyte balance management, and emergency dialysis protocols.

Graphical abstract

Literature
11.
go back to reference Zhi-Yong S (1987) Medical support in Tangshan earthquake: a review of the management of mass casualties and certain majör injuries. J Trauma 27:1130–1136CrossRef Zhi-Yong S (1987) Medical support in Tangshan earthquake: a review of the management of mass casualties and certain majör injuries. J Trauma 27:1130–1136CrossRef
12.
go back to reference Sever MS (2003) What crush syndrome and the marmara earthquake taught. Istanbul:Lebib-Yalkın Publications and Press Houses. 56:372-6 Sever MS (2003) What crush syndrome and the marmara earthquake taught. Istanbul:Lebib-Yalkın Publications and Press Houses. 56:372-6
15.
go back to reference Khan FY (2009) Rhabdomyolysis: a review of the literature. Neth J Med 67:272–283PubMed Khan FY (2009) Rhabdomyolysis: a review of the literature. Neth J Med 67:272–283PubMed
19.
go back to reference Oda J, Tanaka H, Yoshıoka T et al (1997) Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma 42:470–476CrossRefPubMed Oda J, Tanaka H, Yoshıoka T et al (1997) Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma 42:470–476CrossRefPubMed
20.
go back to reference Kuwagata Y, Oda J, Tanaka H et al (1997) Analysis of 2,702 traumatized patients in the 1995 Hanshin-Awaji earthquake. J Trauma 43:427–432CrossRefPubMed Kuwagata Y, Oda J, Tanaka H et al (1997) Analysis of 2,702 traumatized patients in the 1995 Hanshin-Awaji earthquake. J Trauma 43:427–432CrossRefPubMed
25.
go back to reference Erek E, Sever MS (1999) Marmara earthquake and Turkish nephrology. TNDT 4:158–162 Erek E, Sever MS (1999) Marmara earthquake and Turkish nephrology. TNDT 4:158–162
Metadata
Title
Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey
Authors
Ilyas Ozturk
Ozkan Gungor
Savas Ozturk
Refik Olmaz
Ayse Jini Gunes Keskin
Ismail Kocyigit
Murat Hayri Sipahioglu
Fatih Dede
Sena Ulu
Kenan Turgutalp
Dilek Torun
Tuncay Sahutoglu
Fatih Mehmet Erdur
Orcun Altunoren
Ramazan Danis
Gursel Yildiz
Ali Gurel
Mehmet Horoz
Mehmet Kucuksu
Suleyman Karakose
Tolga Yildirim
Mehmet Riza Altiparmak
Mehmet Deniz Ayli
Murat Tugcu
Zehra Eren
Eray Eroglu
Yasemin Coskun Yavuz
Esra Akcali
Dede Sit
Mehmet Polat
Saliha Yildirim
Selma Alagoz
Sibel Gokcay Bek
Irem Pembegul
Tahsin Karaaslan
Mustafa Keles
Funda Sari
Ustun Yilmaz
Numan Gorgulu
Gulizar Sahin
Zeki Aydin
Serap Yadigar
Ozkan Ulutas
Nedim Yilmaz Selcuk
Yavuz Ayar
Didem Turgut
Ozgur Akin Oto
Mehmet Koc
Alaattin Yıldız
Serhan Tuglular
Mehmet Sukru Sever
Publication date
25-09-2024
Publisher
Springer International Publishing
Published in
Journal of Nephrology
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-024-02051-1

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more